PPT-October 2022 I Nasdaq: MDWD

Developing Breakthrough NonSurgical Therapies Improving Patient Lives 2 Cautionary Note Regarding ForwardLooking Statements MediWound cautions you that all statements

complete debridement amp wound debridement complete wound amp patients treatment phase eschar based product surgical enzymatic applications escharex market

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/1038693" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "October 2022 I Nasdaq: MDWD" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.